GTS Securities’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-12,500
Closed -$86.8K 2328
2024
Q3
$86.8K Sell
12,500
-2,000
-14% -$15.7K ﹤0.01% 3822
2024
Q2
$113K Sell
14,500
-600
-4% -$4.44K ﹤0.01% 3591
2024
Q1
$107K Buy
15,100
+800
+6% +$5.29K ﹤0.01% 3511
2023
Q4
$95.8K Sell
14,300
-5,600
-28% -$31.5K ﹤0.01% 3758
2023
Q3
$112K Buy
+19,900
New +$133K ﹤0.01% 3583

Other funds holding GDRX

GTS Securities's GDRX Position: Q1 2024 in Review

GTS Securities sold out of GoodRx Holdings (GDRX) in Q1 2024, closing a stake of 18,204 shares — an estimated $120K sold.

GTS Securities first reported a position in GDRX in Q2 2023 and held it in 3 quarters. The position peaked at $162K in Q2 2023. 159 funds tracked by Wall St. Rank hold GDRX as of Q1 2024.

  • GTS Securities reported no remaining GoodRx Holdings position as of Q1 2024 after selling out during the quarter.
  • GTS Securities sold 18,204 GoodRx Holdings shares in Q1 2024, an estimated $120K.
  • GTS Securities first reported a position in GoodRx Holdings in Q2 2023 and held it in 3 quarters.
  • GTS Securities's GoodRx Holdings position peaked at $162K in Q2 2023.
  • 159 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2024.

Based on GTS Securities's 13F filing for Q1 2024, filed 15 May 2024.